Hepatocellular Carcinoma Clinical Trials in Barcelona
11 recruitingBarcelona, Spain
Showing 1–11 of 11 trials
Recruiting
Phase 1
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
Head and Neck Squamous Cell Carcinoma (HNSCC)Non-small Cell Lung Cancer (NSCLC)Solid Tumor+7 more
Exelixis1,314 enrolled122 locationsNCT05176483
Recruiting
Phase 1
A Study of ZW251 in Participants With Advanced Solid Tumors
Hepatocellular Carcinoma
Zymeworks BC Inc.100 enrolled20 locationsNCT07164313
Recruiting
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
Lung Cancer, Hepatocellular Carcinoma
Hoffmann-La Roche700 enrolled85 locationsNCT07284121
Recruiting
Phase 1
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Gastric CancerEndometrial CancerHepatocellular Carcinoma+5 more
Seagen, a wholly owned subsidiary of Pfizer714 enrolled61 locationsNCT05208762
Recruiting
Phase 2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
Biliary Tract CancerHepatocellular Carcinoma
AstraZeneca294 enrolled60 locationsNCT05775159
Recruiting
Phase 3
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Hepatocellular Carcinoma
AstraZeneca1,220 enrolled204 locationsNCT06921785
Recruiting
Phase 1Phase 2
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
Hepatocellular Carcinoma
AstraZeneca304 enrolled20 locationsNCT06795022
Recruiting
Phase 2Phase 3
A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)
Hepatocellular Carcinoma
AbbVie660 enrolled37 locationsNCT06109272
Recruiting
Phase 3
The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma
Hepatocellular Carcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest434 enrolled72 locationsNCT04803994
Recruiting
Phase 3
Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease.
Hepatocellular CarcinomaAdvanced Chronic Liver DiseasePortal Hypertension
Hospital Universitari Vall d'Hebron Research Institute300 enrolled1 locationNCT06434753
Recruiting
The European NAFLD Registry
Hepatocellular CarcinomaObesityCardiovascular Diseases+9 more
Newcastle University10,000 enrolled37 locationsNCT04442334